Intermittent parathyroid hormone enhances the healing of medication-related osteonecrosis of the jaw lesions in rice rats

Intermittent parathyroid hormone enhances the healing of medication-related osteonecrosis of the jaw lesions in rice rats

Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event in patients treated with antiresorptives. Management of MRONJ is challenging, and no non-antibiotic, established medical treatment exists. Intermittent parathyroid hormone (iPTH) has been used off-label to trea...

Full description

Bibliographic Details
Main Authors:	E. J. Castillo, J. M. Jiron, C. S. Croft, D. G. Freehill, C. M. Castillo, J. Kura, J. F. Yarrow, I. Bhattacharyya, D. B. Kimmel, J. Ignacio Aguirre
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Medicine
Subjects:	anti-resorptives MRONJ periodontitis PTH healing
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1179350/full

Similar Items

The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma
by: Shin-Yu Lu, et al.
Published: (2021-11-01)

Medication-related osteonecrosis of the jaw treatment modalities: A review
by: Amir Ali Asadi
Published: (2020-08-01)

Geranylgeraniol (GGOH), incorporated into a bone cement pellet promotes osteoclast function and healing in a model of medication-related osteonecrosis of the jaw
by: George Feldman, et al.
Published: (2024-03-01)

Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series
by: Filipa Frutuoso, et al.
Published: (2024-09-01)

Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Yong-Dae Kwon, et al.
Published: (2016-11-01)

Medication-Related Osteonecrosis of the Jaw—A Continuing Issue
by: Krzysztof Wróbel, et al.
Published: (2021-08-01)

Pharmacoepidemiology and clinical characteristics of medication-related osteonecrosis of the jaw
by: Hyo-Jeong Son, et al.
Published: (2019-07-01)

Plasma Therapy for Medication-Related Osteonecrosis of the Jaws- A Case Report
by: Maryam Jalili Sadrabad, et al.
Published: (2023-07-01)

A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats
by: Suzanna L. Hatunen, et al.
Published: (2024-08-01)

Treatment of medication-related osteonecrosis of the jaw with cell therapy
by: Cyril Lucien Bouland, et al.
Published: (2024-01-01)

Medication-Related Osteonecrosis of the Jaws: A Comparison of SICMF–SIPMO and AAOMS Guidelines
by: Davide De Cicco, et al.
Published: (2023-06-01)

The Use of Photodynamic Therapy on Medication-Related Osteonecrosis of the Jaws: Animal Study
by: Karapinar Gökay, et al.
Published: (2021-03-01)

Osteonecrosis of the Jaw during Lenvatinib Therapy: A Case Report Based on Surgical Management
by: Gen Udagawa, et al.
Published: (2019-11-01)

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
by: Saad Hajeri, BDS, et al.
Published: (2022-09-01)

Intermittent parathyroid hormone (PTH) promotes cementogenesis and alleviates the catabolic effects of mechanical strain in cementoblasts
by: Yuyu Li, et al.
Published: (2017-04-01)

THE IMPACT OF PURINE DERIVATIVES THERAPY FOR PATIENTS WITH MEDICATION-RELATED OSTEONECROSIS OF THE JAW: PRELIMINARY RESULTS FROM A PILOT STUDY
by: Nader Farajollah, et al.
Published: (2024-09-01)

A Multidisciplinary Pathway for the Diagnosis and Prosthodontic Management of a Patient with Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Amr S. Bugshan, et al.
Published: (2022-08-01)

Clinical values of serum Semaphorin 4D (Sema4D) in medication‑related osteonecrosis of the jaw
by: Hong Mu, et al.
Published: (2023-03-01)

THE IMPACT OF PURINE DERIVATIVES THERAPY FOR PATIENTS WITH MEDICATION-RELATED OSTEONECROSIS OF THE JAW: PRELIMINARY RESULTS FROM A PILOT STUDY – THE SEQUEL
by: Nader Farajollah, et al.
Published: (2024-09-01)

Ultrasonic Navigation for the Treatment of Medication-Related Jaw Osteonecrosis Involving the Inferior Alveolar Nerve: A Case Report and Protocol Review
by: Gerardo Pellegrino, et al.
Published: (2020-10-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw
by: Winnie Zee Man Wat
Published: (2016-10-01)

Osteonecrosis of the Jaws in Patients Receiving Anti-Angiogenic Drugs and Chemotherapeutics: Literature Review and Case Reports
by: Mihaylova Z., et al.
Published: (2019-05-01)

Resective Surgery versus Debridement in Stage 2 Medication-Related Osteonecrosis of the Jaw
by: Salvatore D’Amato, et al.
Published: (2021-09-01)

Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP)
by: L. Landi, et al.
Published: (2023-07-01)

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology
by: Aya Alsalih, et al.
Published: (2021-07-01)

Oral Complications in Cancer Patients–Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Cesar Augusto Migliorati
Published: (2022-04-01)

Dental practitioners' and students' knowledge of medication related osteonecrosis of the jaw (MRONJ)
by: Mandlin Abdulaziz Almousa, et al.
Published: (2021-01-01)

MicroRNA in medication related osteonecrosis of the jaw: a review
by: Siti Salmiah Mohd Yunus, et al.
Published: (2023-04-01)

Medication-related osteonecrosis of the jaw using periodontitis-induced rat before tooth extraction
by: Kyeong-Mee Park, et al.
Published: (2023-08-01)

Conservative non‐surgical management in medication related osteonecrosis of the jaw: A retrospective study
by: Massimo Albanese, et al.
Published: (2020-10-01)

Schemes for Drug-Induced Treatment of Osteonecrosis of Jaws with Particular Emphasis on the Influence of Vitamin D on Therapeutic Effects
by: Filip Michalak, et al.
Published: (2021-03-01)

Secukinumab Causing Medication-Related Osteonecrosis of the Jaw, in a Patient Diagnosed with Psoriasis and Rheumatoid Arthritis
by: Hauer L, et al.
Published: (2024-09-01)

The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
by: Christian Bacci, et al.
Published: (2021-01-01)

Medication‐related osteonecrosis of the jaw and successful implant treatment in a patient on high‐dose antiresorptive medication: A case report
by: Camilla Ottesen, et al.
Published: (2022-10-01)

Role of preoperative SPECT/CT standardized uptake values in medication-related osteonecrosis of the jaw: a preliminary study of SPECT/CT in relation to cone-beam CT and histopathological findings of the resected bone of mandibulectomy
by: Eizaburo Kobayashi, et al.
Published: (2023-06-01)

Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre
by: Benjie Law, et al.
Published: (2021-04-01)

Peri-implant osteonecrosis of the jaw in a patient prescribed selective estrogen receptor modulators
by: Tona Yoshino, et al.
Published: (2023-10-01)

Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents
by: Lukas Hauer, et al.
Published: (2020-03-01)

Advancements in Bone Replacement Techniques–Potential Uses After Maxillary and Mandibular Resections Due to Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Judit Bovari-Biri, et al.
Published: (2025-01-01)